XML 42 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting (Tables)
9 Months Ended
Sep. 30, 2018
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the three and nine-month periods ended September 30, 2018 and 2017, are as follows (in thousands):
Three Months Ended September 30, Nine Months Ended September 30, 
2018 2017 2018 2017 
Net Sales
Cardiovascular
$212,150 $172,723 $624,392 $517,140 
Endoscopy
9,509 6,614 25,112 19,815 
Total net sales
$221,659 $179,337 $649,504 $536,955 
Operating Income (Loss)
Cardiovascular
$18,199 $(1,207)$37,263 $14,239 
Endoscopy
2,862 2,086 7,692 5,611 
Total operating income
$21,061 $879 $44,955 $19,850